Provided by Tiger Trade Technology Pte. Ltd.

GlycoMimetics

15.70
0.0000
Volume:- -
Turnover:171.19K
Market Cap:1.01B
PE:-34.34
High:15.70
Open:15.70
Low:15.70
Close:15.70
52wk High:63.00
52wk Low:14.06
Shares:64.53M
Float Shares:42.78M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4572
EPS(LYR):-0.5875
ROE:-182.66%
ROA:-73.99%
PB:300.17
PE(LYR):-26.72

Loading ...

GlycoMimetics Stockholders Approve Merger with Crescent Biopharma and 1-for-100 Reverse Stock Split

Reuters
·
Jun 06

GlycoMimetics Inc - Reverse Stock Split to Reduce Outstanding Shares to 0.6 Mln

THOMSON REUTERS
·
Jun 06

GlycoMimetics Inc - Board Approves 1-for-100 Reverse Stock Split

THOMSON REUTERS
·
Jun 06

GlycoMimetics Stockholders Approve Proposed Merger With Crescent Biopharma and All Related Proposals

THOMSON REUTERS
·
Jun 06

GlycoMimetics Updates Merger Agreement with Crescent Biopharma, Amends Terms for Third Time

Reuters
·
May 30

GlycoMimetics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 17

GlycoMimetics Inc expected to post a loss of 5 cents a share - Earnings Preview

Reuters
·
May 05

GlycoMimetics Initiated at Overweight by Cantor Fitzgerald

Dow Jones
·
Mar 21

Cantor Fitzgerald Initiates GlycoMimetics at Overweight

MT Newswires Live
·
Mar 21

BRIEF-GlycoMimetics Says Following Termination, Co Will Not Have Any Material Financial Or Other Obligations Under Agreement

Reuters
·
Feb 26

GlycoMimetics : on Feb 19, Received Notice From Apollomics (Hong Kong) Limited Terminating Collaboration and License Agreement

THOMSON REUTERS
·
Feb 26

GlycoMimetics : Following Termination, Co Will Not Have Any Material Financial or Other Obligations Under Agreement

THOMSON REUTERS
·
Feb 26

GlycoMimetics Inc - Amended Agreement for $200 Million Purchase of Crescent Securities

THOMSON REUTERS
·
Feb 15

GlycoMimetics Inc - Co and Crescent Biopharma Amend Merger Agreement

THOMSON REUTERS
·
Feb 15

BRIEF-Glycomimetics Inc Says CEO Harout Semerjian And CFO Brian Hahn To Step Down

Reuters
·
Feb 01

GlycoMimetics Inc - CEO Harout Semerjian and CFO Brian Hahn to Step Down

THOMSON REUTERS
·
Feb 01

BRIEF-GlycoMimetics On Dec 19 Nasdaq Grants Glycomimetics 180 Days To Regain Compliance

Reuters
·
Dec 27, 2024

GlycoMimetics Inc - on Dec 19, Nasdaq Grants GlycoMimetics 180 Days to Regain Compliance

THOMSON REUTERS
·
Dec 27, 2024